- Quick and long term duration of effect of anti TNF therapy with certolizumab in patients with rheumatoid arthritis. Coments to study REALISTIC2013 | First Faculty of Medicine
- Plasma cells as a marker predicting the outcome of anti-TNF therapy2007 | Faculty of Physical Education and Sport
- The role of biological treatment with anti TNF agents in the treatment of rheumatoid arthritis.2008 | First Faculty of Medicine
- Therapeutic strategy after failure of anti-TNF drug2007 | First Faculty of Medicine
- Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA.2009 | First Faculty of Medicine
- Factors effecting efficacy in anti-TNF therapy in clinical practice: Experiences from national registry ATTRA2014 | First Faculty of Medicine
- Use anti-TNF-alfa blockade effect in treatment of rheumatoid arthritis2001 | First Faculty of Medicine
- Plasma cells as a marker predicting the outcome of anti-TNF therapy2007 | First Faculty of Medicine
- Adalimumab in a Clinical Practice - Experience with Human Anti TNF-alpha Therapy in Tertiary Clinical CenterPublication without faculty affiliation
- Can we increase the effectiveness of anti-TNF therapy?2018 | First Faculty of Medicine
- Anti-TNF Therapy in Juvenile Idiopathic Arthritis2008 | First Faculty of Medicine
- Impact of early adalimumab (anti-TNF) therapy on job loss in early rheumatoid arthritis. Comment on the PROWD study.2009 | First Faculty of Medicine
- Biosimilar infliximab in anti-TNF-naïve IBD patients - 1-year clinical follow-up2016 | First Faculty of Medicine
- Certolizumab pegol in the treatment of focal psoriasis2020 | Second Faculty of Medicine
- Tuberculosis and latent tuberculosis in patients with inflammatory bowel disease treated with biologic agents2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)Publication without faculty affiliation
- Circulating miR-145 as a Marker of Therapeutic Response to Anti-TNF Therapy in Patients With Ankylosing Spondylitis2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Biological therapy of osteoporosis2017 | First Faculty of Medicine
- Faecal bacteriome and metabolome profiles associated with decreased mucosal inflammatory activity upon anti-TNF therapy in paediatric Crohn's disease2024 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Successful treatment of recalcitrant gluteal hidradenitis suppurativa with brodalumab after anti-TNF failure2020 | Third Faculty of Medicine
- Promt and long-term effect of golimumab in the treatment of advanced ankylosing spondylitis2012 | Faculty of Medicine in Hradec Králové
- Safety of Anti-TNF-Alpha Therapy During Pregnancy on Longterm Outcome of Exposed Children: A Controlled, Multicenter Observation2019 | First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Biologic therapy of axial spondyloarthritis.2009 | First Faculty of Medicine
- Biologics in the treatment of rheumatoid arthritis2014 | First Faculty of Medicine
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis2011 | First Faculty of Medicine
- Nejen anti-TNF živ je IBD pacient2015 | First Faculty of Medicine
- Immunopathological complications of anti-TNF-alpha biological treatment2016 | First Faculty of Medicine
- Psoriasis - overwiew of the disease and indications for the biological treatment. Our experiences with adalimumab treatment2020 | Faculty of Medicine in Hradec Králové
- Advances in treatment of juvenile idiopathic arthritis associated uveitis2021 | Publication without faculty affiliation
- Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry2020 | First Faculty of Medicine